par Van Laethem, Jean-Luc 
;Marechal, Raphaël
Référence Expert opinion on emerging drugs, 12, 2, page (301-311)
Publication Publié, 2007-05
;Marechal, Raphaël Référence Expert opinion on emerging drugs, 12, 2, page (301-311)
Publication Publié, 2007-05
Article révisé par les pairs
| Titre: |
|
| Auteur: | Van Laethem, Jean-Luc; Marechal, Raphaël |
| Informations sur la publication: | Expert opinion on emerging drugs, 12, 2, page (301-311) |
| Statut de publication: | Publié, 2007-05 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Anti-EGF receptor therapy |
| Antiangiogenic therapy | |
| Chemotherapy | |
| Desmoplastic reaction | |
| Growth factors | |
| Pancreatic cancer | |
| Receptor tyrosine kinase inhibitors | |
| Targeted therapy | |
| Translational research | |
| Xenograft model | |
| MeSH keywords: | Antineoplastic Agents -- administration & dosage |
| Drug Delivery Systems -- methods -- trends | |
| Humans | |
| Pancreatic Neoplasms -- drug therapy -- epidemiology -- metabolism | |
| Signal Transduction -- drug effects -- physiology | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1472-8214 |
| info:doi/10.1517/14728214.12.2.301 | |
| info:scp/34250699015 | |
| info:pmid/17604503 |
